Australian Cannabis Shares Get High on Government Exports

Shares of Cann Group Limited (ASX:CAN), Auscann Group Holdings Ltd (ASX:AC8), Creso Pharma Ltd (ASX:CPH), Stemcell United Ltd (ASX:SCU) and MMJ Phytotech Ltd (ASX:MMJ) have bounced on the Australian Government's export approval.

You’re reading a free article on Rask. Join 4,000+ Australians who get our expert advice, tools, exclusive research and investment recommendations. Get your 30-day trial for $1! Learn more

Shares of Cann Group Limited (ASX: CAN), Auscann Group Holdings Ltd (ASX: AC8), Creso Pharma Ltd (ASX: CPH), Stemcell United Ltd (ASX: SCU) and MMJ Phytotech Ltd (ASX: MMJ) have bounced higher today following the Australian Government’s export approval.

What happened?

Shares of Australia’s major publicly listed medical cannabis companies rallied on Thursday following a decision by the Australian Federal Government Minister Greg Hunt to approve the export of cannabis products overseas.

“We are making these changes because the expanding domestic medicinal cannabis products industry is facing increasing competition from imports,” Minister Hunt said.

The local industry appears to agree.

“…this decision will help ensure Australians benefit from a stronger, economically viable industry that is incentivised to develop world leading medicinal cannabis products to which they will have access,” Peter Crock, CEO of the $350 million Cann Group, said.

“The Federal Government is playing an important leadership role in helping to facilitate easier access for Australian patients and we now see an opportunity for those requirements to be further harmonised at a state level.”

Cann Group is currently developing a cultivation and manufacturing facility and has an agreement with the $6 billion Canadian company, Aurora Cannabis. It recently commissioned a facility north of Melbourne.

Pot Stocks Grow Like Weeds

Cannabis shares throughout the Western world have been a hot topic in recent years, with a push in states throughout the USA and Canada to legalise the drug.

Here in Australia, some commentators and medical experts have called to expedite access to the drug for patients suffering from certain diseases, some of which are terminal and significantly painful.

Minister Hunt said local patients will get priority access to locally produced products.

“It will be a condition of any licence authorising export that medicinal cannabis products be made available, when and if required, to Australian patients first,” Minister Hunt said.

Doctors can apply to become an authorised prescriber and legally distribute medicinal cannabis drugs to patients.

Join Our Free Investing Club Today

Looking to get the latest news and information on investing in Australia? You can join our investing network today by clicking here. It’s free to join.

Keep Reading:

CSL, Xero, ANZ... the ASX is beaten up

Right now, only brave investors are buying. Is ASX Reporting Season your KEY opportunity to act? Buy, or sell.

This coming Monday night, our two most experienced professional investors, Owen Rask and Leigh Gant, are hosting an exclusive and rare webinar on the what to watch this ASX reporting season. LIVE and free

With over 35 years of combined investing experience, join our Chief Investment Officer and Head of Content for our free Q&A.

We’ll be diving into results from CSL, Pro Medicus (ASX: PME), ANZ Bank and more. It’s absolutely free to join us. Take advantage of this volatility with our free playbook. Simply click here to view the topics.

A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

How can Rask help you?

About Rask

Learn more about us, our your community and our mission.

Rask investing philosophy

Nearly 15 years later.
It's still a work in progress.

Online investment community

You won't find our investment community on Facebook or Reddit because it's secure, free and available now.

Join 250,000+ podcast listeners

250,000 investors tune into the Rask podcasts every month. Find out why.

Find a financial planner

Australia's financial experts. At your doorstep.

Free finance courses

35,000 students have enrolled in free Rask courses. We're on a mission to 100,000.

Subscribe to Rask's free investor newsletter

53,000 Australian investors subscribe to our Sunday newsletter... and love it! It's free.

$50 million invested

We manage almost $50 million on behalf of Aussies. Discover how you can invest with us.

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Subscribe to Rask's free investor newsletter

Kick off your week with our pick of podcasts, courses and investing resources to keep your finger on the Rask pulse!

Here you go: A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.